ACUMEN PHARMACEUTICALS INC. - COMMON STOCK
1.0850
01-May-25 10:23:01
15 minutes delayed
Stocks
-0.0450
-3.98%
Today's range
1.0600 - 1.1500
ISIN
N/A
Source
NASDAQ
-
Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Highlights
13 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024
06 Aug 2024 15:00:00 By Nasdaq GlobeNewswire
-
29 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
28 Jul 2024 06:30:00 By Nasdaq GlobeNewswire
-
11 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
14 May 2024 06:00:01 By Nasdaq GlobeNewswire
-
13 May 2024 15:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
08 May 2024 16:47:25 By Nasdaq GlobeNewswire
-
08 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024
07 May 2024 15:00:00 By Nasdaq GlobeNewswire
-
16 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
04 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
26 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
19 Mar 2024 15:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
12 Mar 2024 15:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer
01 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 15:15:20 By Nasdaq GlobeNewswire